Cardiac Marker Testing Devices Market Development by Major Eminent Players, Growth and Forecast 2021 to 2027
Cardiac Marker Testing Devices Market |
Cardiac marker testing detects endogenous
substances that are released during blood circulation, primarily when the heart
is damaged or stressed, thereby assessing risk and directing appropriate
therapy that improves clinical outcomes in high-risk patients. Cardiac markers
are used in hospitals to detect a cardiac injury or to assess future risk of
cardiovascular disease.
The
troponin cardiac biomarkers segment dominated the global cardiac
markers testing market in 2015 and is expected to continue to do so
during the forecast period. This is due to the efficiency and accuracy of its
test results in diagnosing cardiovascular disorders. The global cardiac markers
market is segmented by application, with markers used for myocardial
infarction, acute coronary syndrome (ACS), cardiac heart failure, and others.
ACS is expected to be the fastest-growing segment, owing to the disorder's
increasing prevalence.
Myocardial
infarction is expected to be the second-fastest-growing segment, owing to an
increase in sedentary lifestyles, alcohol consumption, smoking, and unhealthy
food habits, which lead to obesity. The global cardiac markers testing has been
divided into two end-user segments: point-of-care testing and laboratory
testing. The laboratory testing segment dominated the global cardiac markers
testing market in 2015, but the point-of-care testing segment is expected to
gain a disproportionately larger market share during the forecast period.
The
global cardiac markers testing market is divided into creatine kinase (CK),
lactate dehydrogenase, aspartate aminotransferase (AST), troponin, myoglobin,
C-reactive proteins, natriuretic peptides, and others. Creatine kinase is
divided into M and B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac
biomarkers segment dominated the global cardiac markers testing market in 2015
and is expected to continue to do so during the forecast period. This is due to
the efficiency and accuracy of its test results in diagnosing cardiovascular
disorders.
The
global cardiac markers market is segmented by application, with markers used
for myocardial infarction, acute coronary syndrome (ACS), cardiac heart
failure, and others. ACS is expected to be the fastest-growing segment, owing
to the disorder's increasing prevalence. Myocardial infarction is expected to
be the second-fastest-growing segment, owing to an increase in sedentary
lifestyles, alcohol consumption, smoking, and unhealthy food habits, which lead
to obesity. The global cardiac testing market has been divided into two
end-user segments: point-of-care testing and laboratory testing.
Siemens
Healthineers, Bio-Rad Laboratories, Inc., Avantra Biosciences, Becton,
Dickinson and Company, Abbott Laboratories, LSI Medience Corporation, Roche
Diagnostics, Randox Laboratories Ltd., Helomics Corporation, and Enzo Biochem
are major players in the global cardiac markers testing market.
Comments
Post a Comment